Chapter 6
Biotech/Pharma: Taming the Complexity
IN THIS CHAPTER
Understanding how increased regulation impacts biotech and pharmaceuticals
Discovering how AI-enhanced medical, legal, and regulatory review can reduce risk and streamline operations
Identifying the AI techniques used in biotech and pharmaceuticals
Exploring biotech and pharma use cases for AI
The life sciences sector is in a season of transformation. On one hand, price pressure and regulatory requirements place great demands on corporations. Some studies show that the cost of drug development has exploded over the last 20 years while patient outcomes have worsened. Governments around the world are focused on driving down what they perceive as an unacceptably high cost of medicines. The sector is increasingly moving to a value-based pricing model, where payment is determined by demonstrable results. Achieving innovation and outcomes at a lower cost is imperative.
On the other hand, like many other disciplines, biotech and pharmaceuticals have access to a massive wealth of information of all kinds and increased volume, ...
Get Enterprise AI For Dummies now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
